• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C1抑制剂可防止聚乙二醇分级分离诱导的、乙二胺四乙酸抗性的小鼠补体激活。

C1-inhibitor prevents PEG fractionation-induced, EDTA-resistant activation of mouse complement.

作者信息

van den Berg C W, Aerts P C, van Dijk H

机构信息

Eijkman-Winkler Laboratory of Medical Microbiology, Department of Experimental Microbiology, Faculty of Medicine, University of Utrecht, The Netherlands.

出版信息

Mol Immunol. 1992 Mar;29(3):363-9. doi: 10.1016/0161-5890(92)90023-q.

DOI:10.1016/0161-5890(92)90023-q
PMID:1372956
Abstract

Fractionation of mouse serum by precipitation with a critical amount of polyethylene glycol 6000 (PEG; 11% w/v) results in a classical and alternative pathway-independent activation of the terminal complement route. The activation can take place after the separation of an activating principle together with the terminal route components from a natural regulator. The isolation and identification of the regulatory component preventing this activation in serum, is subject of this paper. The regulator was purified by fractionated PEG-precipitation (15-25%), followed by heparin-Sepharose affinity, Mono Q anion-exchange, and Superose 12 gel filtration chromatography. The regulator appeared to be a single-chain protein with a Mr of 96 k. A protein with similar activity purified from human serum had a Mr of 104 k and was functionally and antigenically indistinguishable from C1-INH. The mouse 96 k protein inhibited C1-esterase activity indicating that this protein is indeed C1-INH. Mouse C1-INH regulates the PEG fractionation-induced bypass activation of complement, but does not interfere with the assembly or the lytic activity of membrane attack complexes. alpha 2-Macroglobulin appeared also to be capable of inhibiting the PEG-precipitation-induced activation process, but with lower efficiency.

摘要

用临界量的聚乙二醇6000(PEG;11% w/v)沉淀法对小鼠血清进行分级分离,可导致终末补体途径的经典途径和替代途径非依赖性激活。在将激活因子与终末途径成分从天然调节因子中分离后,激活即可发生。本文的主题是血清中阻止这种激活的调节成分的分离和鉴定。通过分级PEG沉淀(15 - 25%),随后进行肝素-琼脂糖亲和层析、Mono Q阴离子交换层析和Superose 12凝胶过滤层析来纯化调节因子。该调节因子似乎是一种Mr为96 k的单链蛋白。从人血清中纯化的具有类似活性的蛋白Mr为104 k,在功能和抗原性上与C1抑制物(C1-INH)无法区分。小鼠96 k蛋白抑制C1酯酶活性,表明该蛋白确实是C1-INH。小鼠C1-INH调节PEG分级分离诱导的补体旁路激活,但不干扰膜攻击复合物的组装或溶解活性。α2-巨球蛋白似乎也能够抑制PEG沉淀诱导的激活过程,但效率较低。

相似文献

1
C1-inhibitor prevents PEG fractionation-induced, EDTA-resistant activation of mouse complement.C1抑制剂可防止聚乙二醇分级分离诱导的、乙二胺四乙酸抗性的小鼠补体激活。
Mol Immunol. 1992 Mar;29(3):363-9. doi: 10.1016/0161-5890(92)90023-q.
2
Slp is an essential component of an EDTA-resistant activation pathway of mouse complement.Slp是小鼠补体抗EDTA激活途径的一个重要组成部分。
Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10711-5. doi: 10.1073/pnas.89.22.10711.
3
Fluid-phase interaction of C1 inhibitor (C1 Inh) and the subcomponents C1r and C1s of the first component of complement, C1.C1抑制剂(C1 Inh)与补体第一成分C1的亚成分C1r和C1s的液相相互作用。
Biochem J. 1982 Jan 1;201(1):61-70. doi: 10.1042/bj2010061.
4
Improved method for measuring C1-r-C1-s-(C1 inh)2 complexes by an enzyme-linked immunosorbent assay.通过酶联免疫吸附测定法测量C1-r-C1-s-(C1抑制物)2复合物的改进方法。
J Clin Lab Anal. 1995;9(3):196-203. doi: 10.1002/jcla.1860090309.
5
Biosynthesis of complement C1 inhibitor by Hep G2 cells. Reactivity of different glycosylated forms of the inhibitor with C1s.Hep G2细胞对补体C1抑制因子的生物合成。该抑制因子不同糖基化形式与C1s的反应性。
Biochem J. 1986 Jul 1;237(1):93-8. doi: 10.1042/bj2370093.
6
Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.C1的非抗体依赖性激活。二、补体经典途径两类非免疫激活剂的证据。
J Immunol. 1987 Mar 15;138(6):1871-6.
7
Trimer and tetramer complexes containing C1 esterase inhibitor, C1r and C1s, in serum and synovial fluid of patients with rheumatic disease.风湿性疾病患者血清和滑液中含C1酯酶抑制剂、C1r和C1s的三聚体和四聚体复合物。
J Immunol Methods. 1990 May 8;129(1):55-61. doi: 10.1016/0022-1759(90)90420-z.
8
Purification of C1 inhibitor. A new approach for the isolation of this biologically important plasma protease inhibitor.
J Immunol Methods. 1987 May 4;99(1):113-22. doi: 10.1016/0022-1759(87)90039-1.
9
Rapid, activity-guided isolation of sex-limited protein (Slp) from mouse serum by fractionated precipitation and high-performance liquid chromatography.通过分级沉淀和高效液相色谱法从鼠血清中快速、活性导向分离性别限制蛋白(Slp)
J Immunol Methods. 1994 Mar 10;169(2):251-6. doi: 10.1016/0022-1759(94)90269-0.
10
The potentiation of human C1-inhibitor by dextran sulphate is transient in vivo: studies in a rat model.硫酸葡聚糖对人C1抑制剂的增强作用在体内是短暂的:大鼠模型研究。
Int Immunopharmacol. 2001 Aug;1(8):1583-95. doi: 10.1016/s1567-5769(01)00073-x.

引用本文的文献

1
Slp is an essential component of an EDTA-resistant activation pathway of mouse complement.Slp是小鼠补体抗EDTA激活途径的一个重要组成部分。
Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10711-5. doi: 10.1073/pnas.89.22.10711.